Breakthrough in Gene Editing Offers Hope for Treating Incurable Diseases in Babies
Researchers have successfully used CRISPR-Cas9 gene editing to treat an infant with a severe CPS1 deficiency, a genetic disorder affecting ammonia breakdown, marking a significant step in personalized in vivo gene therapy for genetic disorders.